Invesco’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Invesco’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-650,231	Closed	-$34.8M	–	3831
2016 Q1	$34.8M	Buy	650,231 +38,001	+6%	+$2.81M	0.01%	902
2015 Q4	$69.2M	Buy	612,230 +79,123	+15%	+$8.72M	0.03%	638
2015 Q3	$62.8M	Buy	533,107 +106,994	+25%	+$14M	0.03%	647
2015 Q2	$33M	Buy	426,113 +216,034	+103%	+$14.2M	0.01%	1005
2015 Q1	$12.2M	Buy	210,079 +125,034	+147%	+$5.31M	﹤0.01%	1454
2014 Q4	$2.74M	Buy	85,045 +45,665	+116%	+$1.37M	﹤0.01%	2327
2014 Q3	$964K	Buy	+39,380	New	+$800K	﹤0.01%	2993
2014 Q2	–	Sell	-274,270	Closed	-$5.49M	–	4176
2014 Q1	$5.49M	Buy	274,270 +119,013	+77%	+$2.31M	﹤0.01%	1869
2013 Q4	$2.6M	Buy	155,257 +17,627	+13%	+$244K	﹤0.01%	2493
2013 Q3	$1.46M	Buy	+137,630	New	+$1.2M	﹤0.01%	2769

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Invesco's ANAC Position: Q2 2016 in Review

Invesco sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 650,231 shares — an estimated $34.8M sold.

Invesco first reported a position in ANAC in Q3 2013 and held it in 10 quarters. The position peaked at $69.2M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Invesco reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Invesco sold 650,231 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $34.8M.
Invesco first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 10 quarters.
Invesco's ANACOR PHARMACEUTICALS INC COM position peaked at $69.2M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Invesco's 13F filing for Q2 2016, filed 15 Aug 2016.